COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.

NCT00377481 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: darbepoetin alfa
DRUG: epoetin beta [NeoRecormon]

Sponsor

Hoffmann-La Roche